opioid
FDA approves Pfizer’s abuse-deterrent opioid painkiller
August 22, 2016Sales and Marketing FDA, Pfizer, abuse deterrent, abuse-deterrent, approval, opioid, troxyca
Pfizer has announced that the US FDA has approved Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) extended-release capsules for the …
Endo to withdraw FDA application for abuse-deterrent labelling on opioid drug
August 15, 2016Sales and Marketing Endo, Endo International, abuse deterrent, opioid
Endo International has announced that, following discussions with the US Food and Drug Administration (FDA), it has decided to withdraw …
FDA approves first buprenorphine implant for opioid dependence
May 27, 2016Medical Communications, Sales and Marketing FDA, addiction, buprenorphine, dependence, implant, opioid, probuphine
The US Food and Drug Administration (FDA) has approved Probuphine, which is the first buprenorphine implant for the maintenance treatment …
Latest content
Migraine annual economic and quality-of-life burden in UK
October 1, 2026
bit.bio expands human heart cell portfolio through myriamed partnership
September 30, 2026
Phoenix Labs acquires Kent Pharma
September 29, 2026
Astoriom acquires Sampled’s UK stability storage operations
September 28, 2026
